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AmotL1Paramyxovirus matrix (M) proteins organize virus assembly, functioning as adapters that link together viral
ribonucleoprotein complexes and viral glycoproteins at infected cell plasma membranes. M proteins may
also function to recruit and manipulate host factors to assist virus budding, similar to retroviral Gag proteins.
By yeast two-hybrid screening, angiomotin-like 1 (AmotL1) was identiﬁed as a host factor that interacts with
the M protein of parainﬂuenza virus 5 (PIV5). AmotL1-M protein interaction was observed in yeast, in
transfected mammalian cells, and in virus-infected cells. Binding was mapped to a 83-amino acid region
derived from the C-terminal portion of AmotL1. Overexpression of M-binding AmotL1-derived polypeptides
potently inhibited production of PIV5 VLPs and impaired virus budding. Expression of these polypeptides
moderately inhibited production of mumps VLPs, but had no effect on production of Nipah VLPs. siRNA-
mediated depletion of AmotL1 protein reduced PIV5 budding, suggesting that this interaction is beneﬁcial to
paramyxovirus infection.
© 2009 Elsevier Inc. All rights reserved.Introduction
Paramyxovirus particles, like those of other enveloped viruses, are
formed by budding from cellular membranes. Budding occurs after
viral structural components, including viral glycoproteins and viral
ribonucleoprotein complexes (RNPs), have assembled together on
infected cell plasma membranes (reviewed in (Schmitt and Lamb,
2004; Takimoto and Portner, 2004). Paramyxovirus assembly is
coordinated by viral matrix (M) proteins, which occupy a position
in virions that is between the glycoproteins and the RNPs. M proteins
interact strongly with cellular membranes, and are known to self-
oligomerize, forming dense layers along the inner surfaces of plasma
membranes. During virus assembly, M proteins are thought to interact
directly with the cytoplasmic tails of viral glycoproteins, and also with
the nucleocapsid (NP) protein components of RNPs, effectively
bridging these elements and concentrating them at locations from
which virus particles will bud (reviewed in (Schmitt and Lamb, 2004;
Takimoto and Portner, 2004).
For many paramyxoviruses, the processes of particle formation
and release have been recapitulated in cells transfected to produce
one ormore viral proteins. The resulting virus-like particles (VLPs) areand Biomedical Sciences, The
niversity Park, PA 16802, USA.
ll rights reserved.morphologically similar to authentic virions and have proven to be
useful tools for dissecting steps involved in virus exit. Not surprisingly,
paramyxovirus VLP production is critically dependent on the presence
of the viral M proteins (Schmitt and Lamb, 2004). Nonetheless,
substantial differences have been identiﬁed among paramyxoviruses
in the requirements for efﬁcient VLP production. For example, optimal
production of Sendai VLPs requires expression of the viral C protein in
addition to the M protein and viral glycoproteins (Sugahara et al.,
2004). For the rubulaviruses, which do not encode C proteins, efﬁcient
VLP production requires co-expression of M proteins together with
NP proteins and viral glycoproteins (fusion (F) protein for mumps
virus; F protein or hemagglutinin-neuraminidase (HN) protein for
parainﬂuenza virus 5 (PIV5)) (Li et al., 2009; Schmitt et al., 2002).
Other paramyxoviruses, including Newcastle disease virus and Nipah
virus (NiV), produce VLPs very efﬁciently even when M protein is
expressed by itself (Ciancanelli and Basler, 2006; Pantua et al., 2006;
Patch et al., 2008). Here, VLP production does not appear to increase
upon co-expression of other viral proteins, although the co-expressed
proteins are efﬁciently incorporated into the budding particles.
PIV5 (formerly SV5) is a prototype paramyxovirus. Like other
paramyxoviruses, it possesses an RNA genome of negative-sense
polarity that is encapsidated by the viral NP protein. The encapsidated
genome is associated with the viral RNA-dependent RNA polymerase
complex, composed of large (L) protein and phospho (P) protein
subunits. Together, these components comprise the viral RNP core.
The core is packaged into a viral envelope, which is obtained from the
Fig. 1. Schematic illustration of AmotL1 protein and AmotL1-derived polypeptides.
Numbers indicate the span of amino acid residues derived from AmotL1 that is
contained within each construct. Checkered regions denote Flag tags, and solid black
regions denote HA tags. Stars mark the positions of the two PPPEY sequences, and
diamonds are used to indicate replacement of PPPEY with PAAEY.
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envelope contains densely-packed integral membrane spike proteins.
The HN protein facilitates virion attachment to target cells by binding
to sialic acid receptors and, in addition, possesses a sialidase activity
that allows newly-formed virions to separate from infected cells. The F
protein mediates fusion between viral and host cell membranes
during virus entry. The small hydrophobic (SH) protein is a low-
abundancemembrane component that functions to block apoptosis of
infected cells (He et al., 2001). The viral envelope is linked to the RNP
core by the highly-abundant M protein.
Enveloped viruses typically do not encode all of the machinery
necessary for proper transport, assembly, and budding of virus
particles. Instead, host machinery is manipulated to allow efﬁcient
virus exit. For example, many retroviruses employ protein–protein
interaction sequences (late domains)within their Gag polypeptides to
recruit host factors to virus assembly sites (reviewed in (Bieniasz,
2005; Calistri et al., 2009; Chen and Lamb, 2008; Freed, 2002).
Preventing this host factor recruitment signiﬁcantly impairs retrovi-
rus budding in many cases (Bieniasz, 2005; Freed, 2003; Fujii et al.,
2007). The same late domains found in retroviruses are also present in
the matrix proteins of some negative-strand RNA viruses such as
Ebola virus (Harty et al., 2000) and Lassa fever virus (Perez et al.,
2003), suggesting that the overall strategy of host protein manipula-
tion to achieve efﬁcient virus budding is highly conserved. Conse-
quently, it is thought that paramyxovirus M proteins are also likely to
bind host factors to facilitate virus exit. These M proteins lack the
prototypical PPxY, P[T/S]AP, and YP(x)nL late domains found in
retroviral Gag proteins, suggesting that the details of host factor
recruitment must be different for the paramyxoviruses. Alternative
sequences have been identiﬁed in several paramyxovirus M proteins
that have been proposed to direct host factor recruitment. These
include the sequence FPIV within the PIV5 M protein (Schmitt et al.,
2005), the sequence YLDL within the Sendai virus M protein (Irie et
al., 2006), and the sequences YMYL (Ciancanelli and Basler, 2006) and
YPLGVG (Patch et al., 2008) within the NiV M protein.
In this study, yeast two-hybrid screening was conducted in an
attempt to identify host proteins that interact with the PIV5 M
protein. Among the candidates identiﬁed was human angiomotin-like
1 (AmotL1), a tight junction-localized protein that contains PPxY
motifs as well as a PDZ-binding motif. AmotL1 is thought to function
in cells to allow normal endothelial migration and has been shown to
colocalize with F-actin (Gagne et al., 2009; Zheng et al., 2009). Here,
AmotL1 is shown to interact with PIV5 M protein in yeast, in
transfected mammalian cells, and in virus-infected cells. Binding was
mapped to a C-terminal region of the AmotL1 protein, and occurred
independent of the FPIV sequence within PIV5 M protein. Over-
expression of the C-terminal region of AmotL1 inhibited the budding
of PIV5-like particles, and siRNA depletion of AmotL1 reduced the
budding efﬁciency of PIV5. These results provide the ﬁrst demonstra-
tion of physical and functional interaction between a host factor and a
rubulavirus M protein.
Results
Identiﬁcation of PIV5 M-interacting host proteins by yeast
two-hybrid screening
To deﬁne cellular proteins that interact with PIV5 M protein, a
yeast two-hybrid screening strategy was employed. To this end, two
bait expression plasmids were constructed: one encodes full-length
PIV5 M protein with LexA DNA binding domain fused to its N-
terminus, and the other encodes full-length PIV5 M protein with LexA
DNA binding domain fused to its C-terminus. Each of these could be
expressed efﬁciently in yeast cells as judged by immunoblotting, and
neither self-activated transcription in yeast (not shown). A premade
HeLa cell-derived cDNA library containing 9.6×106 primary cloneswas screened using each of the two PIV5 M protein baits. The screens
were performed in yeast strain L40, in which transcription of LexA-
driven reporters results in the production of beta-galactosidase, and
also allows growth of yeast cells on media lacking histidine.
Approximately 5×107 clones were screened with each of the two
baits. Library-derived cDNAs were PCR-ampliﬁed from His+, beta-
galactosidase+ yeast colonies, and analyzed by DNA sequencing. Each
of the two screens identiﬁed several candidate PIV5 M-interacting
proteins, but only one of these candidates, angiomotin-like 1
(AmotL1), was identiﬁed in both screens.
Human AmotL1 (GenBank NM_130847; largest potential isoform)
is a 956 amino acid long protein. AmotL1 (also known as JEAP)
belongs to a family of proteins called the motins, together with
angiomotin (Amot) and angiomotin-like 2 (AmotL2) (Bratt et al.,
2002). These proteins are known to have cellular functions related to
endothelial cell migration, angiogenesis, embryonic cell movements,
and maintenance of cell polarity (Bratt et al., 2005; Gagne et al., 2009;
Huang et al., 2007; Levchenko et al., 2003; Shimono and Behringer,
2003; Troyanovsky et al., 2001; Zheng et al., 2009). The N-terminal
region of AmotL1 protein contains a glutamine-rich domain, and two
PPPEY sequences. The central region of the protein contains a coiled-
coil domain, and at the C-terminal end of the AmotL1 protein is a PDZ-
binding motif (Fig. 1). None of the AmotL1 prey sequences identiﬁed
by yeast two-hybrid screening corresponded to the full-length
protein. Rather, all of these sequences corresponded to one of three
AmotL1 subfragments designated here as AmotL1-a, AmotL1-b, and
AmotL1-c (Fig. 1). Each of the three prey fragments was identiﬁed
multiple times and with both baits. A short region of overlap is
common to all three fragments. The overlap region spans amino acid
residues 667–749 of the full-length protein, and corresponds to the C-
terminal portion of the coiled-coil region.
Pairwise yeast two-hybrid assays were used to conﬁrm the
screening results. Prey plasmid DNAs were isolated from His+, beta-
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into fresh L40 yeast together with bait plasmids. Beta-galactosidase
activities of the transformants were measured using a colony ﬁlter
assay. As shown in Fig. 2, each of the three AmotL1-derived preys
tested positive for interaction with both of the PIV5M baits, but tested
negative for interaction with unfused LexA DNA binding domain.
AmotL1 interacts with PIV5 M protein in mammalian cells
To test whether AmotL1 can bind to M protein in mammalian cells
capable of supporting paramyxovirus infection, co-immunoprecipita-
tion experiments were performed. In the ﬁrst experiment, PIV5-
infected or mock-infected 293T cells were transfected to produce
AmotL1-b, which corresponds to the smallest prey fragment identi-
ﬁed by yeast two-hybrid screening. Immunoprecipitation of PIV5 M
protein resulted in the co-precipitation of AmotL1-b, as judged by
immunoblotting with AmotL1-speciﬁc antibody (Fig. 3A). To conﬁrm
and further explore this interaction, additional experiments were
conducted using the reverse procedure (immunoprecipitation of
AmotL1 followed by immunodetection of M protein; Fig. 3B). For
these experiments, a series of Flag-tagged AmotL1 protein derivatives
were constructed as illustrated in Fig. 1. These include full-length
AmotL1 protein (Fl-AmotL1), the N-terminal 70% of AmotL1 protein
(AmotL1-Nt) and the C-terminal 30% of AmotL1 protein (AmotL1-Ct).
Note that the region of overlap among the three AmotL1 prey
fragments recovered in the yeast two-hybrid screen–the region that is
anticipated to direct binding to M protein–is contained within
AmotL1-Ct and is absent from AmotL1-Nt. The Flag-tagged AmotL1
constructs were expressed in 293T cells together with PIV5M protein,
by transient transfection. Precipitation of Fl-AmotL1 with Flag tag-
speciﬁc antibody resulted in co-precipitation of PIV5 M protein,
judged by immunoblotting with M protein-speciﬁc antibody (Fig. 3B,
left panel). Likewise, precipitation of AmotL1-Ct led to co-precipita-
tion of M protein. Precipitation of AmotL1-Nt, on the other hand, led
to no detectable co-precipitation of M protein. Similar results were
obtained in a related experiment in which cells were metabolically
labeled and the immunoprecipitated proteins detected directly using
a phosphorimager (Fig. 3C). Again, PIV5 M protein co-precipitated
with Fl-AmotL1 and AmotL1-Ct, but not with AmotL1-Nt. These
results suggested that elements within the N-terminal region of
AmotL1 protein, including the two PPPEY sequences, are not
important for the PIV5 M protein interaction. To further rule out
involvement of the PPPEY sequences, a mutated version of full-length
AmotL1 was generated in which both copies of PPPEY were changed
to PAAEY. PIV5 M protein was co-precipitated with AmotL1-PAAEY
similar to the co-precipitation with Fl-AmotL1, conﬁrming that the
PPPEY sequences do not contribute to this interaction (Fig. 3C). An
additional AmotL1 derivative, AmotL1-m, comprising only the 83
amino acid long overlap region within the C-terminal part of AmotL1Fig. 2. Interaction between PIV5 M protein and AmotL1 detected with a pairwise yeast
two-hybrid assay. Yeast cells (strain L40) were transformed with plasmids
corresponding to the indicated baits, and then transformed a second time with
plasmids corresponding to the indicated preys. Growing yeast colonies were selected,
suspended in water, and spotted onto a nitrocellulose membrane in replicates of four.
Yeast cells on the membrane were disrupted with freeze-thaw cycles, and beta-
galactosidase activity was detected using the colorimetric substrate X-gal.found in the three yeast two-hybrid preys, was also examined. PIV5M
protein was co-precipitated efﬁciently with this small AmotL1-m
polypeptide (Fig. 3C). These results are consistent with those obtained
by yeast two-hybrid screening and deﬁne a region comprising amino
acid residues 667 to 749 of AmotL1 that can direct binding to PIV5 M
protein in transfected mammalian cells.
Additional AmotL1 co-precipitation experiments were performed
in cells expressing the PIV5 M, NP, and HN proteins together. Under
this circumstance, the viral M protein is known to be actively engaged
in the budding process, evidenced by the efﬁcient production of VLPs
(Schmitt et al., 2002). Here, M protein was co-precipitated together
with Fl-AmotL1 and with AmotL1-Ct (but not with AmotL1-Nt),
similar to the results obtained in the absence of NP and HN protein
coexpression (Fig. 3B, left panel). Additional experiments were
conducted to conﬁrm these results in virus-infected cells, and once
again binding was observed with Fl-AmotL1 and AmotL1-Ct, but not
with AmotL1-Nt (Fig. 3B, right panel). Hence, this interaction can be
detected in virus infected cells, in VLP-producing cells, and in
transfected cells expressing PIV5 M protein in the absence of any
other viral proteins. To test whether the FPIV sequence within PIV5 M
protein, proposed to function as a protein–protein interaction domain
(Schmitt et al., 2005), is important for the AmotL1-M protein
interaction, co-immunoprecipitation experiments were carried out
in cells transfected to produce AmotL1-Ct together with PIV5 M.P21A,
in which the FPIV sequence has been disrupted (Schmitt et al., 2005).
Co-precipitation of the mutant M protein was still observed in this
case, indicating that this interaction is not FPIV-dependent (Fig. 3D).
To explore the possibility that AmotL1 might interact with other
viral matrix proteins in addition to the PIV5 M protein, co-
immunoprecipitation experiments were carried out using the MuV
and NiV M proteins. Co-precipitation of the MuV M protein with Fl-
AmotL1 and with AmotL1-Ct could be detected (Fig. 4), but these
signals were relatively faint, suggesting a weak interaction approach-
ing the limits of detection with this assay system. We did not detect
co-precipitation of NiV M protein with any of the AmotL1-derived
fragments (not shown). These results indicate that AmotL1 protein
interacts with only a subset of viral matrix proteins, and suggest that
the binding to PIV5 M protein is more efﬁcient than the binding to
MuV M protein.
Overexpression of M-binding AmotL1 fragments blocks production of
PIV5 VLPs
Short fragments of host proteins that bind to viral Gag or M
proteins are often potent inhibitors of virus budding, likely because
they either act as competitive inhibitors and prevent binding by the
endogenous host proteins, or otherwise disrupt viral protein function
on binding (Chen et al., 2005; Demirov et al., 2002; Freed, 2003; Fujii
et al., 2007; Martin-Serrano et al., 2003; Munshi et al., 2006). To test
the possibility that expression of M-interacting AmotL1 fragments
might affect the production of PIV5 particles, 293T cells were
transfected with various AmotL1-derived fragments together with
the PIV5 M, NP, and F proteins for VLP production. After metabolic
labeling of transfected cells, VLPs were collected from the culture
medium, puriﬁed by centrifugation through sucrose cushions, further
puriﬁed by ﬂotation on sucrose gradients, and loaded directly onto
SDS gels. As expected, VLP production was efﬁcient in cells lacking
exogenous AmotL1 expression, as well as in cells expressing AmotL1-
Nt that fails to bind M protein (Fig. 5A). In contrast, VLP production
was markedly inhibited in cells expressing either of the two M-
binding AmotL1 fragments, AmotL1-Ct and AmotL1-m. Overexpres-
sion of full-length AmotL1 protein also reduced VLP production,
although in this case the reduction (to about 55% of the normal level
on average) was more variable and not as severe as that observed
upon expression of the smaller M-binding AmotL1 fragments. VLP
production was quantiﬁed on the basis of M protein content,
Fig. 3. Interaction between PIV5 M protein and AmotL1 in mammalian cells detected by co-immunoprecipitation. (A) 293T cells were infected with PIV5 or were mock-infected. At
6 h p.i., cells were transfected with a pCAGGS plasmid to produce AmotL1-b. Cell lysates were subjected to immunoprecipitation with mouse anti-PIV5 M monoclonal antibody. A
portion of each cell lysate was reserved and not subjected to immunoprecipitation. Immunoprecipitated proteins, as well as the reserved total cell lysate fractions, were fractionated
by SDS-PAGE and analyzed by immunoblotting with either a rabbit polyclonal anti-AmotL1 antibody or a rabbit polyclonal anti-PIV5M antibody. (B) 293T cells were transfectedwith
pCAGGS plasmids to produce the indicated Flag-tagged AmotL1-derived polypeptides together with PIV5M protein, or together with PIV5M, NP, and HN proteins. Alternatively, cells
were ﬁrst infected with PIV5, and at 6 h p.i. were transfected to produce AmotL1-derived polypeptides. Cell lysates were processed for immunoprecipitation with mouse anti-Flag
monoclonal antibody. Immunoprecipitated proteins were fractionated by SDS-PAGE and analyzed by immunoblotting with a rabbit polyclonal anti-PIV5 M antibody. (C) 293T cells
were transfected to produce PIV5 M protein together with the indicated Flag-tagged AmotL1-derived polypeptides. Proteins synthesized in the transfected cells were metabolically
labeled using 35S amino acids. Cell lysates were processed for immunoprecipitation with either a mouse monoclonal anti-PIV5 M antibody (left-most lane) or a mouse monoclonal
anti-Flag antibody (all other lanes). Immunoprecipitated proteins were fractionated by SDS-PAGE and detected using a phosphorimager. (D) 293T cells were transfected with
pCAGGS plasmids to produce AmotL1-Ct together with either wt PIV5 M protein or M.P21A protein in which the sequence 20-FPIV-23 is disrupted, as indicated. Cell lysates were
processed for immunoprecipitation withmouse anti-Flagmonoclonal antibody. Immunoprecipitated proteins were fractionated by SDS-PAGE and analyzed by immunoblotting with
a rabbit polyclonal anti-PIV5 M antibody. Each result shown is a representative example of at least three independent experiments.
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results from three independent experiments were analyzed (Fig. 5B).
Expression of AmotL1-Ct or AmotL1-m reduced VLP production to
levels that were approximately 10% of those obtained in the absence
of AmotL1 overexpression (Fig. 5B). A similar inhibitory effect was
observed on the production of VLPs harboring HN glycoprotein in
place of F protein (Fig. 5C), consistent with the notion that this
inhibition is mediated through binding to the viral M protein, and not
through targeting viral glycoproteins (which are also critical for VLP
production). Together, these results deﬁne a short, 83 amino acid long
AmotL1-derived polypeptide that potently blocks PIV5-like particle
production when expressed in transfected cells.
We considered the possibility that the two PPPEY sequences
within AmotL1 protein might function to indirectly recruit to PIV5
assembly sites the same WW domain-containing ubiquitin ligases
that are directly recruited by the PPxY late domains important for the
budding of Rous sarcoma virus, Ebola virus, and other enveloped
viruses (reviewed in (Bieniasz, 2005; Calistri et al., 2009; Freed, 2002).In this case, we reasoned that overexpression of AmotL1-PAAEY, in
which both PPxY sequences are disrupted, might have a potent
inhibitory effect on VLP production, as the nonfunctioning AmotL1-
PAAEY would act as a competitive inhibitor and prevent interaction
with endogenous AmotL1. However, overexpression of AmotL1-
PAAEY led only to a moderate effect on VLP production that was
indistinguishable from the effect of Fl-AmotL1 overexpression
(Fig. 5A–C). While this result does not rule out the possibility that
AmotL1 PPPEY domains contribute to PIV5 budding, no positive
evidence in support of this hypothesis has yet been obtained.
To further explore the potential of M-binding AmotL1-derived
polypeptides as inhibitors of virus particle production, cells were
infected with PIV5, followed by transient transfection to produce
these polypeptides. This experiment is somewhat limited due to
incomplete overlap of AmotL1-transfected and PIV5-infected cell
populations, a general limitation that has been characterized
previously for PIV5 infections (He et al., 2002). Nonetheless, a
moderate reduction in virion production was observed in cells
Fig. 4. Co-immunoprecipitation of mumps virus M protein with AmotL1. 293T cells
were transfected with pCAGGS plasmids to produce the indicated Flag-tagged AmotL1-
derived polypeptides together with MuV M protein. Cell lysates were processed for
immunoprecipitation with mouse anti-Flag monoclonal antibody. Immunoprecipitated
proteins were fractionated by SDS-PAGE and analyzed by immunoblotting with a rabbit
polyclonal anti-MuV M antibody. The data shown is representative of two independent
experiments.
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observed in the absence of AmotL1-m expression (Fig. 5D). A more
signiﬁcant effect on PIV5 particle production was observed upon
expression of AmotL1-Ct (Fig. 5E), as particle production in this case
was reduced to levels that were 44% of control levels, on average.
Thus, expression of M-binding AmotL1-derived polypeptides nega-
tively affects PIV5 virion production from infected cells.
To determine if AmotL1-derived polypeptides can more generally
affect the assembly and budding of paramyxovirus particles, AmotL1-
Ct was expressed in 293T cells via transient transfection together
with the NiV M protein for production of Nipah VLPs, or with the MuV
M, NP, and F proteins for production of mumps VLPs (Fig. 6).
Expression of AmotL1-Ct had no effect on Nipah M-alone VLP
production. However, a moderate effect was observed on mumps
VLP production, with particle release falling to levels that were on
average about 55% of those obtained in the absence of AmotL1-Ct
expression. These results are consistent with co-immunoprecipitation
results, as there was a correlation between the ability of paramyxo-
virus M proteins to bind AmotL1-derived polypeptides and the
susceptibility of the corresponding VLPs to AmotL1 fragment-
mediated inhibition.
Depletion of AmotL1 from cells reduces PIV5 virion production
To assess the importance of endogenous AmotL1 protein for PIV5
particle production, a series of AmotL1-speciﬁc siRNAs were obtained.
Of ﬁve siRNAs tested, two were partially effective at reducing
endogenous full-length AmotL1 protein accumulation in 293T cells,
judged by immunoblotting (Figs. 7A, B), with protein levels reduced
to approximately 25% of control levels. To measure the effect of
AmotL1 depletion on virion formation and release, cells transfected
with AmotL1-speciﬁc siRNAs or control siRNA were infected with
PIV5. siRNA-mediated AmotL1 depletion led to moderate but
statistically signiﬁcant reductions in the production of PIV5 virions
(Figs. 7C, D). Depletion mediated by siRNA #2 led to PIV5 virion
production that was 66% of control levels on average, while depletion
mediated by siRNA #5 led to levels that were 41% of control levels
(Fig. 7D). For these experiments, virion production was measured as
the amount of M protein detected in particles, without normalizing to
M protein expression in cell lysates. This is because somewhat
elevated levels of M protein were consistently detected in cell lysates
transfected with siRNA #5, compared with those transfected with
siRNA #2 and control siRNA. This had the effect of potentially
overestimating the effect of siRNA #5 on virion production (when
normalized to cell lysate M protein content, budding efﬁciency aftersiRNA #5 transfection was 35% of control levels, on average). Overall,
these results are consistent with the possibility that efﬁcient PIV5
particle production is, in part, dependent on the presence of
physiological levels of AmotL1 protein within host cells.
Discussion
Host factors are recruited and manipulated to assist assembly and
budding of a wide variety of enveloped viruses including retroviruses
such as HIV-1 and Rous sarcoma virus, as well as negative-strand RNA
viruses such as Ebola virus and Lassa fever virus. In many cases, these
host factors are recruited by viral late domains, and are thought to
facilitate the pinching off of virions from infected cells (reviewed in
(Bieniasz, 2005; Calistri et al., 2009). Relatively little is known about
the contributions of host proteins to paramyxovirus budding,
however, and prior to this studyM-interacting host proteins recruited
during infections by many paramyxoviruses, such as PIV5 andmumps
virus, had not been identiﬁed. Here, host protein AmotL1 was
identiﬁed as a PIV5 M-interacting factor, and M-binding ability was
mapped to a region of AmotL1 protein that spans amino acid residues
667 to 749. Interaction between PIV5 M protein and AmotL1 was
observed in yeast, in transfected mammalian cells, and in virus-
infected cells. siRNA-mediated depletion of AmotL1 protein reduced
PIV5 budding efﬁciency. Remarkably, M-binding AmotL1 fragments
acted as potent inhibitors of PIV5-like particle production, and also
inhibited the production of virions from virus-infected cells. Thus, the
binding interface between the AmotL1 and PIV5 M proteins
represents a possible target for the inhibition of virus replication.
Motin proteins have been characterized mainly as factors that
regulate migration of endothelial cells which line the surfaces of
capillaries and larger blood vessels (Bratt et al., 2005; Troyanovsky et
al., 2001; Zheng et al., 2009). The best-studied of the three motins is
Amot, whichwas initially identiﬁed in a yeast two-hybrid screen as an
angiostatin-binding protein (Troyanovsky et al., 2001), and which can
function to promote tumor angiogenesis (Holmgren et al., 2006;
Levchenko et al., 2004; Levchenko et al., 2008). The other motin
proteins, AmotL1 and AmotL2, share glutamine rich domains,
conserved coiled coil regions, and C-terminal PDZ-binding domains
with Amot, but apparently lack the angiostatin-binding domain (Bratt
et al., 2002). Amot and AmotL1 localize together at endothelial tight
junctions and regulate the maintenance of endothelial cell polarity
and junction stability (Bratt et al., 2005; Zheng et al., 2009). In
addition to controlling migration and polarity of endothelial cells,
motin proteins also function in epithelial cells, the primary targets of
infection bymany respiratory viruses including PIV5. AmotL1was ﬁrst
identiﬁed as a tight junction-associated protein in epithelial cells
(Nishimura et al., 2002). Endogenous levels of all threemotin proteins
can be detected in epithelial cells, where they are found to localize to
tight junctions as well as to apical membranes and vesicular
compartments within the cytoplasm (Sugihara-Mizuno et al., 2007).
All three motin proteins interact via their PDZ-binding domains with
Patj, a critical regulator of epithelial cell tight junction formation
(Ernkvist et al., 2008; Michel et al., 2005; Shin et al., 2005; Sugihara-
Mizuno et al., 2007; Wells et al., 2006), and Amot has been shown to
be a functional component of Patj-containing polarity complexes,
necessary for long-term stability of epithelial cell tight junctions
(Wells et al., 2006). PIV5, like many other paramyxoviruses as well as
inﬂuenza A virus, buds preferentially from apical surfaces of polarized
epithelial cells (Blau and Compans, 1995; Boulan and Sabatini, 1978).
It is possible that the trafﬁcking of PIV5 components to apical
membranes in preparation for polarized budding could be facilitated
by AmotL1-M protein interaction. Efforts are currently underway to
assess the importance of AmotL1 and other motin proteins in
polarized budding of PIV5 by mapping the AmotL1-binding region
within PIV5 M protein, which will potentially allow the generation of
binding-defective recombinant viruses.
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Fig. 6. Overexpression of AmotL1 fragments affects the production of mumps VLPs, but not the production of Nipah VLPs. (A) 293T cells were transfected to express the indicated
Flag-tagged AmotL1-derived polypeptides, together with the NiV M protein for production of Nipah VLPs, the MuV M, NP, and F proteins for the production of mumps VLPs, or the
PIV5 M, NP, and F proteins for the production of PIV5 VLPs. Radiolabeled proteins from cell lysates were collected by immunoprecipitation using antibodies speciﬁc to each of the
viral proteins expressed, together with anti-Flag antibody. VLPs from culture supernatants were puriﬁed by centrifugation through sucrose cushions and ﬂotation on sucrose
gradients. Viral proteins from both cell lysates and puriﬁed VLPs were fractionated by SDS-PAGE and detected using a phosphorimager. (B) Relative VLP production efﬁciency values
were calculated from three independent experiments performed as in (A), with standard deviations indicated by error bars.
161Z. Pei et al. / Virology 397 (2010) 155–166Two distinct isoforms of Amot have been characterized. In addition
to the p80 isoform which promotes endothelial cell migration, a p130
Amot splice isoform has been identiﬁed in cells and shown to interact
with actin ﬁbers, inﬂuencing cell shape (Ernkvist et al., 2006). Recent
evidence also links AmotL1 to the actin cytoskeleton, as AmotL1 co-
localizes with F-actin, and expression of exogenous full-length
AmotL1 protein modiﬁes the architecture of the actin cytoskeleton,
causing F-actin to adopt a punctate-like appearance (Gagne et al.,Fig. 5. Overexpression of M-binding AmotL1 fragments blocks production of PIV5 VLPs. (
polypeptides, together with the PIV5 M, NP, and F proteins for VLP production. Radiolabele
antibodies speciﬁc to the PIV5 M, NP, and F proteins together with anti-Flag antibody. VLPs f
ﬂotation on sucrose gradients. Viral proteins from both cell lysates and puriﬁed VLPs were
production was calculated as the amount of M protein detected in VLPs divided by the amoun
the value obtained in the absence of AmotL1 expression. Relative VLP production efﬁciency
standard deviations indicated by error bars. (C) The effect of AmotL1-derived polypeptide ex
co-expression of PIV5 M, NP, and HN proteins, instead of PIV5 M, NP, and F proteins, and HN-
result shown is representative of three independent experiments. (D) 293T cells were infecte
Radiolabeled proteins from cell lysates were collected by immunoprecipitation using a mix
antibody. Virions from culture supernatants were puriﬁed by centrifugation through sucros
puriﬁed virions were fractionated by SDS-PAGE and detected using a phosphorimager. The re
derived polypeptide expression on virion production was measured as in (D), except that A
was calculated from four independent experiments. Differences from control values (no Am
values b0.01 denoted by ⁎⁎.2009). Paramyxovirus assembly and budding has long been thought
to involve the actin cytoskeleton. Large quantities of actin are
contained within the virions of Sendai virus, mumps virus, and
other paramyxoviruses (Lamb et al., 1976; Orvell, 1978; Takimoto and
Portner, 2004; Ulloa et al., 1998). Recruitment of actin to paramyxo-
virus assembly sites may occur via interactions with the viral M
proteins (Giuffre et al., 1982; Takimoto et al., 2001). Treatment of
infected cells with cytochalasin D or nocodazole to disrupt the actinA) 293T cells were transfected to express the indicated Flag-tagged AmotL1-derived
d proteins from cell lysates were collected by immunoprecipitation using a mixture of
rom culture supernatants were puriﬁed by centrifugation through sucrose cushions and
fractionated by SDS-PAGE and detected using a phosphorimager. (B) Efﬁciency of VLP
t of M protein detected in the corresponding cell lysate, and was normalized relative to
values were calculated from four independent experiments performed as in (A), with
pression on VLP production was measured as in (A) except that VLPs resulted from the
speciﬁc antibody was used for immunoprecipitation in place of F-speciﬁc antibody. The
d with PIV5, followed by transfection with the indicated AmotL1-derived polypeptides.
ture of antibodies speciﬁc to the PIV5 M, NP, and HN proteins together with anti-Flag
e cushions and ﬂotation on sucrose gradients. Viral proteins from both cell lysates and
sult shown is representative of two independent experiments. (E) The effect of AmotL1-
motL1-Ct was expressed in place of AmotL1-m. Relative efﬁciency of virion production
otL1 expression) were assessed for statistical signiﬁcance using Student's t test, with P
Fig. 7. Depletion of AmotL1 reduced PIV5 budding. (A) 293T cells were transfected with siRNAs speciﬁc to AmotL1, or with an unrelated control siRNA. At 72 h p.t., cell lysates were
prepared and AmotL1 protein levels were measured by immunoblotting using a rabbit polyclonal AmotL1-speciﬁc antibody. (B) AmotL1 protein levels were quantiﬁed from three
independent experiments performed as in (A), using a Storm 860 imaging system. Standard deviations are indicated by error bars. (C) 293T cells were transfected with the indicated
siRNAs. At 24 h p.t., cells were infected with PIV5. Radiolabeled viral proteins from infected cell lysates were collected by immunoprecipitation using antibodies speciﬁc to the PIV5
M, NP, and HN proteins. Virions from culture supernatants were puriﬁed by centrifugation through sucrose cushions and ﬂotation on sucrose gradients. Viral proteins from both cell
lysates and puriﬁed virions were fractionated by SDS-PAGE and detected using a phosphorimager. (D) Virion production was calculated as the amount of M protein detected in
virions, and was normalized relative to the value obtained in cells transfected with control siRNA. Relative virion production values were calculated from three independent
experiments, with standard deviations indicated by error bars. Differences from control values were assessed for statistical signiﬁcance using Student's t test, with P valuesb0.05
denoted by ⁎ and P valuesb0.01 denoted by ⁎⁎.
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virus and respiratory syncytial virus (Burke et al., 1998; Stallcup et al.,
1983). Here, overexpression of full-length AmotL1 protein resulted in
a moderate decrease in PIV5-like particle production (Figs. 5A–C). It is
plausible that this decrease, to about half of the normal particle
release efﬁciency, could have been caused by modiﬁcations to the
actin cytoskeleton as a result of AmotL1 overexpression in the
transfected cells. It is unlikely, however, that modiﬁcation of the actin
cytoskeleton can account for the much larger decreases in PIV5-like
particle production that were observed upon overexpression of
AmotL1-Ct or AmotL1-m, as these two AmotL1 fragments are both
derived from the C-terminal half of the protein, which lacks the ability
to colocalize with F-actin (Gagne et al., 2009). We did consider the
possibility that overexpression of these short M-binding fragments of
AmotL1 might prevent endogenous AmotL1 protein from binding
with M protein, and thereby affect potential M protein interplay withcellular actin through AmotL1. However, if the main contribution of
AmotL1 to PIV5 assembly was to facilitate M protein interaction with
actin, then one might have expected incorporation of actin into
PIV5 virions to have been affected by AmotL1-m overexpression or
by siRNA-mediated AmotL1 depletion, and this was not observed
(Figs. 5D and 7C).
PPxY motifs function as late domains necessary for the efﬁcient
budding of many enveloped viruses, including Rous sarcoma virus
(Parent et al., 1995), murine leukemia virus (Yuan et al., 1999), Ebola
virus (Harty et al., 2000), vesicular stomatitis virus (Craven et al.,
1999), and Lassa fever virus (Perez et al., 2003). Recruitment of
WW domain-containing Nedd4-like ubiquitin ligases to virus assem-
bly sites is thought to facilitate the pinching off of virus particles,
although the precisemechanism bywhich these host factors inﬂuence
virus budding is unclear. Ubiquitin is thought to have an important
role in virus budding (reviewed in (Martin-Serrano, 2007), and
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through PPxY-mediated host factor recruitment. It is also possible that
Nedd4-like proteins function mainly as adapters, allowing the further
recruitment of other host factors to virus budding sites in a way that is
independent of ubiquitin ligase activity (Martin-Serrano et al., 2004).
The experiments described here present the interesting possibility
that PIV5 might recruit WW domain-containing host proteins
indirectly to virus assembly sites via AmotL1, which harbors two
PPxY motifs in its N-terminal region. If this is the case, we reasoned
that overexpression of PPxY-disrupted AmotL1 protein should result
in competitive inhibition and prevent such recruitment via endoge-
nous AmotL1. However, overexpression of PPxY-disrupted AmotL1
protein did not affect particle production to any greater extent than
overexpression of wt AmotL1. Thus, no positive evidence in support of
a role for AmotL1 PPxY motifs in PIV5 budding has been obtained.
Nonetheless, further investigation is warranted to determine if WW
domain-containing Nedd4-like proteins are indeed associated with
PIV5 M protein through AmotL1.
In addition to PPxY, enveloped viruses are known to recruit host
factors for budding via a number of other protein interaction motifs
including P[T/S]AP and YP(x)nL (reviewed in (Bieniasz, 2005; Calistri
et al., 2009; Freed, 2002). Although these late domain sequences
direct interactions to separate host factors, they can function
interchangeably in some cases to allow virus budding (Accola et al.,
2000; Craven et al., 1999; Li et al., 2002; Yuan et al., 2000). Indeed, an
additional late domain sequence, FPIV, derived from the N-terminal
region of PIV5 M protein and critical for PIV5 budding, was identiﬁed
on the basis of its ability to restore budding function to PTAP-
disrupted HIV-1 Gag protein (Schmitt et al., 2005). Mumps virus
contains a similar sequence, FPVI, within its N-terminal region that is
necessary for efﬁcient budding of mumps VLPs (Li et al., 2009). FPIV-
like sequences presumably function to recruit host factors to virus
assembly sites, similar to other viral late domains. Hence, identiﬁca-
tion of speciﬁc host proteins that bind to paramyxovirus M proteins
via FPIV-like sequences is an important goal towards understanding
paramyxovirus budding mechanisms. Here, we describe for the ﬁrst
time a speciﬁc interaction between a host protein and PIV5M protein.
This AmotL1-M protein interaction, readily detected by co-immuno-
precipitation in transfected as well as virus-infected cells, was not
substantially affected when wt M protein was replaced with mutant
M protein in which the critical proline residue within FPIV was
changed to alanine (Fig. 3D). Thus, AmotL1 does not appear to be
recruited to PIV5 assembly sites via FPIV. However, it remains possible
that PIV5 M protein interacts, either simultaneously or sequentially,
with multiple host proteins during its intracellular transport,
assembly, and release from cells.
M-binding AmotL1-derived polypeptides were potent inhibitors
of PIV5-like particle production, and also negatively affected the
production of mumps VLPs and the production of PIV5 virions from
infected cells. The shortest of these M-binding fragments, AmotL1-
m, is just 83 amino acid residues in length yet caused ten-fold
reduction of PIV5 VLP production efﬁciency. These results parallel
earlier ﬁndings made with retroviral Gag-binding host factors
Tsg101 and Alix. Expression of a Gag-binding fragment of Tsg101
(TSG-5') caused a 60% reduction in HIV-1 particle production
(Demirov et al., 2002; Freed, 2003). Similarly, expression of Gag-
binding fragments of Aip1/Alix reduced HIV-1 and equine infectious
anemia virus particle production by 5- to 10-fold (Chen et al., 2005;
Fujii et al., 2007; Martin-Serrano et al., 2003; Munshi et al., 2006).
Even expression of full-length Aip1/Alix was found to reduce virus
particle production (Chen et al., 2005), providing a further similarity
to results described here in which expression of full-length AmotL1
partially inhibited PIV5-like particle production. Together, these
studies reinforce the general notion that binding interfaces between
host proteins and viral Gag or M proteins represent potentially
attractive targets for antiviral drug design (Harty, 2009). In the caseof HIV-1, the structure of Tsg101 in complex with a PTAP-
containing peptide has been determined, opening new doors for
rational design of antiviral drugs that disrupt this critical interaction
(Freed, 2003; Pornillos et al., 2002). Our ﬁndings suggest that
generally similar approaches may also be effective towards
combating paramyxovirus pathogens.
Materials and methods
Plasmids
Plasmids pHybLex-PIV5 M-Zeo and pHyb-PIV5 M-LexZeo were
constructed by subcloning full-length PIV5 M protein cDNA into the
yeast two-hybrid bait plasmid pHybLexZeo (Invitrogen, Carlsbad, CA)
to generate hybrid proteins with LexA DNA binding domain appended
to the N-terminus or the C-terminus of PIV5 M protein, respectively.
Cloning details will be provided upon request.
cDNA corresponding to full-length human AmotL1 (GenBank
accession no. NM_130847) was obtained from OriGene Technologies
(Rockville, MD). This sequence was ampliﬁed and modiﬁed by PCR to
incorporate an N-terminal Flag tag (amino sequence DYKDDDDK),
and the product was subcloned into the eukaryotic expression
plasmid pCAGGS (Niwa et al., 1991), to generate plasmid pCAGGS-
Fl-AmotL1. Subfragments of AmotL1 were ampliﬁed by PCR using full-
length AmotL1 cDNA as template, with boundaries and positioning of
Flag tags and HA tags as illustrated in Fig. 1. The products were
subcloned into pCAGGS to generate pCAGGS-AmotL1-a, pCAGGS
AmotL1-b, pCAGGS-AmotL1-c, pCAGGS-AmotL1-m, pCAGGS-
AmotL1-Nt, and pCAGGS-AmotL1-Ct. pCAGGS-AmotL1-PAAEY was
generated by PCR mutagenesis of pCAGGS-Fl-AmotL1, ﬁrst changing
the PPPEY sequence spanning amino acid residues 309–313 to PAAEY,
and then using this product as template for a second round of PCR
mutagenesis changing the PPPEY sequence spanning amino acid
residues 366–370 to PAAEY. Nucleotide sequences of all AmotL1-
derived plasmids were veriﬁed by DNA sequencing of the entire
AmotL1 coding regions (Macrogen Inc., South Korea).
The plasmids pCAGGS-PIV5 M, pCAGGS-PIV5 NP, pCAGGS-PIV5
HN, and pCAGGS-PIV5 F were kind gifts of Robert Lamb (Northwest-
ern University, Evanston, IL) (Schmitt et al., 2002). The plasmid
pCAGGS-PIV5M.P21A in which the sequence 20-FPIV-23 within PIV5
M protein is changed to 20-FAIV-23 has been described before
(Schmitt et al., 2005). The plasmids pCAGGS-MuV M, pCAGGS-MuV
NP, and pCAGGS-MuV F that express the M, NP, and F proteins,
respectively, of mumps virus strain 88-1961, have been described
previously (Li et al., 2009). Plasmid pCAGGS-NiV M has also been
described previously (Li et al., 2009).
Antibodies
Monoclonal antibodies M-h, HN1b, and NPa, speciﬁc to the PIV5M,
HN, and NP proteins, respectively, were kind gifts of Richard Randall
(St. Andrews University, St. Andrews, Scotland, United Kingdom)
(Randall et al., 1987). Polyclonal antibodies speciﬁc to the MuVM, NP,
and F proteins, as well as the NiV M protein, were generated as
described previously (Li et al., 2009). Polyclonal antibodies Fsol,
speciﬁc to the PIV5 F protein, and Dudet, speciﬁc to the PIV5 M
protein, were kind gifts of Robert Lamb (Northwestern University,
Evanston, IL). To generate antibody speciﬁc to AmotL1 protein, full-
length AmotL1 cDNAwas subcloned into plasmid pRSETB (Invitrogen,
Carlsbad, CA) and the protein was expressed in Escherichia coli by
autoinduction (Studier, 2005). The resulting His-tagged recombinant
protein was puriﬁed by metal afﬁnity chromatography and sent to
Harlan Bioproducts for Science (Indianapolis, IN) for rabbit immuni-
zation and polyclonal antibody production. Monoclonal antibody
speciﬁc to Flag tag (clone M2) was purchased from Stratagene
(La Jolla, CA).
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Yeast two-hybrid screening and assays were performed accord-
ing to the manufacturer's instructions for the Hybrid Hunter yeast
two-hybrid system (Invitrogen, Carlsbad, CA) using yeast strain L40
in which LexA-driven transcription results in expression of both
histidine and beta-galactosidase reporters. Brieﬂy, yeast cells were
transformed with either of the two bait plasmids pHybLex-PIV5 M-
Zeo or pHyb-PIV5 M-LexZeo, and selection was maintained with
Zeocin. Yeast cells harboring the bait plasmids were transformed
with a pre-made HeLa cell-derived yeast two-hybrid cDNA library
constructed in plasmid pJG4-5 in which preys are fused with B42
transcription activation domain (Invitrogen, Carlsbad, CA). For
screening, transformants were plated on synthetic medium lacking
tryptophan, uracil, lysine, and histidine and containing 300 µg/ml
Zeocin. After incubation for 3 days at 30 °C, growing colonies were
selected as primary positives and further tested using a beta-
galactosidase colony ﬁlter assay, as instructed by the manufacturer.
Yeast clones testing positive were subjected to DNA sequence
analysis using prey plasmid-speciﬁc primer sets. For pairwise
assays to conﬁrm binding in yeast, prey plasmids were isolated
from His+, beta-galactosidase+ yeast clones. Prey plasmids were
re-transformed into L40 cells harboring pHybLex-PIV5 M-Zeo,
pHyb-PIV5 M-LexZeo, or the empty bait plasmid pHybLexZeo.
Beta-galactosidase activity was measured in replicates of four using
a colony ﬁlter assay.
Co-immunoprecipitation
293T cells in 10-cm-diameter dishes (70 to 80% conﬂuent) grown
in Dulbecco's modiﬁed Eagle medium (DMEM) supplemented with
10% fetal bovine serum were transfected with pCAGGS plasmids
encoding PIV5 M protein (0.8 µg of plasmid DNA per dish), MuV M
protein (0.4 µg of plasmid DNA per dish), or NiV M protein (0.8 µg
of plasmid DNA per dish) together with plasmids encoding AmotL1-
derived polypeptides (1.5 µg of plasmid DNA per dish). Transfec-
tions were supplemented with a pCAGGS plasmid lacking an insert
when necessary to equalize total plasmid DNA quantities. For co-
immunoprecipitation from virus-infected cells, 293T cells were
infected with PIV5 at a multiplicity of infection (MOI) of 1 plaque
forming unit (PFU)/cell. At 6 h post-infection (p.i.), the cells were
transfected with plasmids encoding AmotL1-derived polypeptides
(1.5 µg of plasmid DNA per dish). Transfection experiments were
performed in Opti-MEM using Lipofectamine-Plus reagents (Invitro-
gen, Carlsbad, CA). At 16 h post-transfection (p.t.), cells were
washed with ice-cold phosphate-buffered saline (PBS), suspended in
whole cell extract buffer (20 mM Tris–HCl, pH 7.5; 280 mM NaCl;
10% glycerol; 0.5% Nonidet P-40; 2 mM EGTA; 0.2 mM EDTA;
100 mM phenylmethylsulphonyl ﬂuoride), and incubated on ice for
30 min. After centrifugation for 10 min at 14,000g, lysate super-
natants were precleared with protein A-Sepharose (Invitrogen,
Carlsbad, CA) for 30 min at 4 °C, followed by incubation for 3 h at
4 °C with Flag tag-speciﬁc antibody, or with mouse monoclonal
antibody speciﬁc to PIV5 M protein. Immune complexes were
incubated with protein A-Sepharose for 30 min at 4 °C, and the resin
was then washed twice with whole cell extract buffer. Immunopre-
cipitated proteins were eluted from the resin with sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) loading
buffer containing 2.5% (wt/vol) dithiothreitol. Samples were
fractionated by SDS-PAGE using 10% gels and transferred to PVDF
membranes. Immunodetection was carried out using rabbit poly-
clonal antibodies speciﬁc to AmotL1 protein, PIV5 M protein, or MuV
M protein, followed by alkaline phosphatase-conjugated goat anti-
rabbit secondary antibody (Jackson ImmunoResearch Laboratories,
Inc., West Grove, PA). A Storm 860 laser scanner was used for
detection (GE Healthcare, Piscataway, NJ).Alternatively, for co-precipitation of radiolabeled proteins, 293T
cells were transfected as described above. At 16 h p.t., culture media
was replaced with DMEM lacking methionine and cysteine. After
30min, this media was replacedwith fresh DMEM lackingmethionine
and cysteine, supplemented with 40 µCi of [35S]Promix/ml (Perkin
Elmer, Waltham, MA). After an additional 2 h, the cells were
harvested, lysed, and subjected to immunoprecipitation analysis as
described above. Samples were fractionated by SDS-PAGE using 10%
gels and protein bands were detected using a Storm 860 laser scanner.
Measurements of VLP production and virion production
For VLP production, 293T cells in 10-cm-diameter dishes were
transfected with plasmids encoding viral proteins or AmotL1-derived
polypeptides as described above. Plasmid quantities per dish were as
follows: pCAGGS-PIV5 M, 800 ng; pCAGGS-PIV5 NP, 300 ng; pCAGSS-
PIV5 F, 3.0 µg; pCAGGS-PIV5 HN, 3.0 µg; pCAGGS-MuV M, 800 ng;
pCAGGS-MuV NP, 250 ng; pCAGGS-MuV F, 1.5 µg; pCAGGS-NiV M,
1.6 µg; pCAGGS-Fl-AmotL1 and derivatives, 1.5 µg. Transfections were
supplemented with a pCAGGS plasmid lacking an insert when
necessary to equalize total plasmid DNA quantities. For virion
production, 293T cells were infected with PIV5 at a MOI of 1 PFU/
cell. At 6 h p.i., the cells were transfected with plasmids encoding
AmotL1-derived polypeptides.
At 16 h p.t., the culture medium was replaced with DMEM
containing 1/10 the normal amounts of methionine and cysteine and
40 µCi of [35S]Promix/ml. After an additional 24 h, the cells and media
were harvested for protein expression and VLP/virion production
analysis.
To analyze the VLPs or virions released from cells, culture media
were centrifuged at 7500g for 2 min to remove cell debris and then
layered onto 20% sucrose cushions (10 ml in NTE [0.1 M NaCl; 0.01 M
Tris–HCl, pH 7.4; 0.001 M EDTA]). Samples were centrifuged at
140,000g for 1.5 h. Pellets were resuspended in 0.5 ml of NTE and
mixed with 1.3 ml of 80% sucrose in NTE. Layers containing 50%
sucrose (1.8 ml) and 10% sucrose (0.6 ml) in NTE were applied to the
tops of the samples, which were then centrifuged at 110,000g for 3 h.
A 2.1-ml volume was collected from the top of each gradient, and
VLPs/virions contained within this ﬂoated fraction were pelleted by
centrifugation at 140,000g for 1.5 h. VLP/virion pellets were
resuspended in SDS-PAGE loading buffer containing 2.5% (wt/vol)
dithiothreitol.
Cell lysate preparation and immunoprecipitation of proteins was
performed as described previously (Schmitt et al., 2002). Immuno-
precipitated proteins from cell lysates as well as puriﬁed VLPs from
culture media were analyzed by SDS-PAGE using 10% gels. Detection
and quantiﬁcation were performed using either a Storm 860 laser
scanner or a Fuji FLA-7000 laser scanner (FujiFilm Medical Systems,
Stamford, CT). Budding efﬁciency was calculated as the M-protein-
speciﬁc counts in culture media divided by the M-protein-speciﬁc
counts in the corresponding cell lysates and was normalized relative
to values obtained in control experiments.
RNA interference
siRNAs targeting AmotL1 as well as control siRNA GL3 targeting
luciferase were purchased from Sigma (Saint Louis, MO). AmotL1
siRNA#2 targets the sequence 5'CCAACAUGCCGGAAUACAA3'. AmotL1
siRNA #5 targets the sequence 5'GAAUGAUUUGAACUGAUAA3'. 293T
cells in 6-cm diameter dishes (50–60% conﬂuent) were transfected
with 30 pmol/dish of siRNA using Lipofectamine and Plus reagents. At
24h p.t., the cellswere infectedwith PIV5 at aMOI of 1 PFU/cell. At 24h
p.i., the culturemediumwas replacedwith DMEM containing 1/10 the
normal amounts ofmethionine and cysteine and20µCi of [35S]Promix/
ml. After an additional 24 h, the cells and media were harvested for
protein expression and virion production analysis as described above.
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